LV12957B - Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-3-(1-methylethylamino)-2-pyridinyl]piperazine - Google Patents

Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-3-(1-methylethylamino)-2-pyridinyl]piperazine Download PDF

Info

Publication number
LV12957B
LV12957B LVP-02-186A LV020186A LV12957B LV 12957 B LV12957 B LV 12957B LV 020186 A LV020186 A LV 020186A LV 12957 B LV12957 B LV 12957B
Authority
LV
Latvia
Prior art keywords
carbonyl
methylethylamino
pyridinyl
methanesulfonamidoindolyl
piperazine
Prior art date
Application number
LVP-02-186A
Other languages
English (en)
Latvian (lv)
Inventor
Jeffrey L Havens
Donald P Smith
Michael S Bergren
Mark A Lyster
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of LV12957B publication Critical patent/LV12957B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
LVP-02-186A 1994-04-15 2002-10-24 Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-3-(1-methylethylamino)-2-pyridinyl]piperazine LV12957B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22786094A 1994-04-15 1994-04-15
US31178094A 1994-09-23 1994-09-23

Publications (1)

Publication Number Publication Date
LV12957B true LV12957B (en) 2003-04-20

Family

ID=26921831

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-02-186A LV12957B (en) 1994-04-15 2002-10-24 Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-3-(1-methylethylamino)-2-pyridinyl]piperazine

Country Status (26)

Country Link
US (1) US6452007B1 (de)
EP (1) EP0755393B1 (de)
JP (1) JP3817261B2 (de)
KR (1) KR100364941B1 (de)
CN (1) CN1147253A (de)
AT (1) ATE207481T1 (de)
AU (1) AU693939B2 (de)
CA (1) CA2184598C (de)
CZ (1) CZ287164B6 (de)
DE (1) DE69523447T2 (de)
DK (1) DK0755393T3 (de)
ES (1) ES2164147T3 (de)
FI (1) FI111364B (de)
HU (1) HU226827B1 (de)
IL (1) IL113162A (de)
LV (1) LV12957B (de)
MX (1) MX9604831A (de)
MY (1) MY116830A (de)
NO (1) NO310024B1 (de)
NZ (1) NZ282211A (de)
PL (1) PL180776B1 (de)
PT (1) PT755393E (de)
RU (1) RU2136677C1 (de)
SK (1) SK282424B6 (de)
TW (1) TW393478B (de)
WO (1) WO1995028398A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE349203T1 (de) 1998-06-11 2007-01-15 Pharmacia & Upjohn Co Llc Delavirdin tablettenformulierung
US6872811B1 (en) 1998-09-30 2005-03-29 Millennium Pharmaceuticals, Inc. HRPCa9 and HRPCa10 nucleic acids and polypeptides
GB0219660D0 (en) * 2002-08-23 2002-10-02 Astrazeneca Ab Therapeutic use
DE102011113749A1 (de) * 2011-09-14 2013-03-14 Aicuris Gmbh & Co. Kg Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565924A (en) 1968-07-01 1971-02-23 Wisconsin Alumni Res Found 25-hydroxycholfcalciferol
US3833622A (en) 1969-03-17 1974-09-03 Upjohn Co Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
GB1532682A (en) 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
IL63968A (en) 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
MX9203454A (es) * 1989-12-28 1992-08-01 Upjohn Co Compuestos anti sida diaromaticos substituidos.
US5563142A (en) * 1989-12-28 1996-10-08 The Upjohn Company Diaromatic substituted compounds as anti-HIV-1 agents
US5599930A (en) * 1991-07-03 1997-02-04 The Upjohn Company Substituted indoles as anti-AIDS pharmaceuticals

Also Published As

Publication number Publication date
ES2164147T3 (es) 2002-02-16
JP3817261B2 (ja) 2006-09-06
FI964114A0 (fi) 1996-10-14
SK282424B6 (sk) 2002-01-07
US6452007B1 (en) 2002-09-17
EP0755393B1 (de) 2001-10-24
ATE207481T1 (de) 2001-11-15
EP0755393A1 (de) 1997-01-29
NO964386D0 (no) 1996-10-15
HUT76467A (en) 1997-09-29
CZ287164B6 (en) 2000-10-11
NO310024B1 (no) 2001-05-07
PT755393E (pt) 2002-04-29
MY116830A (en) 2004-04-30
AU693939B2 (en) 1998-07-09
IL113162A (en) 1999-04-11
FI111364B (fi) 2003-07-15
PL180776B1 (pl) 2001-04-30
PL316688A1 (en) 1997-02-03
CN1147253A (zh) 1997-04-09
DK0755393T3 (da) 2001-12-17
RU2136677C1 (ru) 1999-09-10
FI964114L (fi) 1996-10-14
KR100364941B1 (ko) 2003-02-19
NZ282211A (en) 1997-10-24
SK122996A3 (en) 1997-05-07
JPH09512007A (ja) 1997-12-02
DE69523447T2 (de) 2002-05-16
CA2184598C (en) 2005-05-03
MX9604831A (es) 1998-05-31
AU3513695A (en) 1995-11-10
WO1995028398A1 (en) 1995-10-26
NO964386L (no) 1996-10-15
CZ294296A3 (en) 1997-01-15
IL113162A0 (en) 1995-06-29
DE69523447D1 (de) 2001-11-29
CA2184598A1 (en) 1995-10-26
HU226827B1 (en) 2009-11-30
TW393478B (en) 2000-06-11
HU9602857D0 (en) 1996-12-30
KR970702275A (ko) 1997-05-13

Similar Documents

Publication Publication Date Title
US8269003B2 (en) Stable crystal form of imatinib mesylate and process for the preparation thereof
ES2811478T3 (es) Nueva sal de adición de ácido de 1-(5-(2,4-difluorofenil)-1-((3-fluorofenil)sulfonil)-4-metoxi-1H-pirrol-3-il)-N-metilmetanamina
EP0579681B1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
KR102402501B1 (ko) 피마살탄 트로메타민염 및 이를 포함하는 약제학적 조성물
US6452007B1 (en) Crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine
US10155740B2 (en) Crystal forms of immunomodulatory drug pomalidomide and co-crystal with gentisic acid
AU2004232495B2 (en) 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo [2, 3d]pyrimidine hydrogen mesylate and its polymorphic forms
US7521472B2 (en) Crystal of two-ring heterocyclic sulfonamide compound
WO2004020433A1 (ja) 新規結晶
EP4660195A1 (de) Kristalline formen von avatrombopagmaleat und herstellung davon
CN102548971B (zh) 罗苏伐他汀锌盐的晶型i
JP3228557B2 (ja) シクロヘキセノン化合物及び該化合物を有効成分とする脳機能改善薬
JP5308030B2 (ja) ケモカインレセプターアンタゴニストの固体形態およびその使用方法
WO2024056079A1 (zh) 内匹司他酸加成盐的多晶型及其制备方法和用途
WO2013058361A1 (ja) アンドロゲン受容体拮抗化合物の結晶
HU190589B (en) Process for preparing acid additional salts of 4-chloro-phenoxy-acetic acid-1,3-bis/dimethyl-amino/-2-propyl-ester